# E-DRUG: Economics of antiretroviral manufacturing (cont'd)

**URL:** <https://talk.edrugplus.org/t/e-drug-economics-of-antiretroviral-manufacturing-contd/2463>\
**Category:** e-drug\
**Created:** [April 17, 1998, 6:44am UTC](https://talk.edrugplus.org/t/e-drug-economics-of-antiretroviral-manufacturing-contd/2463 "1998-04-17T06:44:00Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Rob\_Verhage](https://avatars.discourse-cdn.com/v4/letter/r/5daacb/32.png) [@Rob\_Verhage](https://talk.edrugplus.org/u/Rob_Verhage)\
**Post date:** [April 17, 1998, 6:44am UTC](https://talk.edrugplus.org/t/e-drug-economics-of-antiretroviral-manufacturing-contd/2463/1 "1998-04-17T06:44:00Z")

</div>

E-drug: Economics of antiretroviral manufacturing (cont'd)  
-----------------------------------------------------

In reaction to the E-drug contribution of Chris Green on production of  
ARV drugs in developing countries, I believe his reasoning is correct  
and I can add the "know-how" as another element necessary for  
production. This may be a very costly aspect here.

> From a PHC point of view the approach to prevent HIV-infection is still

priority policy in developing countries. By investing more in this  
approach, results may become better.

On the other hand I am surprised that minimal or no discussion is  
taking place in developing countries themselves on how to make  
ARV-drugs available to the people. Is it another burden when most  
essential drugs are not available anyway?

I think that availability of ARV drugs is in principle not a different  
problem than general availability of essential drugs. And we know about  
the policy and options of that problem, as we work on it every day. It  
should be treated no different, I think. Which would mean that  
discussions should take place to add the drugs in the Essential Drug  
Lists or not, etc..

Best regards,

Rob Verhage  
Procurement Advisor  
Ministry of Health  
Accra, Ghana  
E-mail: 106573.3254@compuserve.com  
--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
